Undertreatment of Vasomotor Symptoms: A Menopausal "Hot Topic"
neuroscienceCME Medical Simulation
Premiere Date: Friday, September 28, 2012This activity offers CE credit for:
- Physicians (CME)
- Nurses (CNE)
- Pharmacists (ACPE)
- Other
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Monday, September 1, 2014
Note: Credit Is No Longer Available
 | Holly L. Thacker, MD, FACP Director, Center for Specialized Womens Health Associate Professor of Surgery Cleveland Clinic Lerner College of Medicine-CWRU Cleveland, OH |
 | Lynn Pattimakiel, MD Women's Health Fellow Cleveland Clinic Main Campus Cleveland, OH |
Co-provided by
Imagine yourself suddenly whisked into a narrow hallway lined with hundreds of hairdryers aimed at you, dialed to the highest heat setting and blowing vigorously. This—an imaginary diversion for you—is the several-times-a-day experience of thousands of women who experience moderate to severe vasomotor symptoms (VMS) associated with the menopausal transition (i.e., hot flashes, night sweats). Despite the significance of this complaint in terms of prevalence and morbidity, data support that menopausal VMS is undertreated because of both patient-related and practice-based gaps. Thus, important opportunities exist for clinicians to improve care and change outcomes for these women.
This CME/CE activity is designed to help clinicians seize these opportunities via medical simulation. Here, clinicians are in the driver’s seat as the decision-makers, providing care for a patient across two or three clinical encounters. As such, clinicians have the opportunity to put their knowledge into practice with this virtual patient. This serves as the basis for translating their experiences to their practices with actual patients.
- Williams RE, Kalilani L, DiBenedetti DB, et al. Frequency and severity of vasomotor symptoms among peri- and postmenopausal women in the United States. Climacteric. 2008;11:32-43. PMID: 18202963.
- Lewis V. Undertreatment of menopausal symptoms and novel options for comprehensive management. Curr Med Res Opin. 2009;25(11):2689-2698. PMID: 19775194.
To increase knowledge and use of existing treatment recommendations and expert opinion to improve care of women with vasomotor symptoms and to individualize approaches and tailor to VMS management to each woman.
At the end of this CE activity, participants should be able to:
- Evaluate the rationale for existing treatment recommendations and recent expert thought supporting the use of hormone therapy for moderate to severe, menopause-associated vasomotor symptoms (VMS).
- Accurately handle patient queries about non-hormonal therapies for menopause-associated VMS, including emerging options, and complementary and alternative strategies.
- Conduct systematic treatment trials in women with menopausal-associated VMS in order to arrive at the best therapy for the individual patient.
Supported by an educational grant from Pfizer Inc.
Physicians, physician assistants, nurses, nurse practitioners, pharmacists, and other health care professionals who provide gynecologic or primary care to women in midlife.
CME Credit (Physicians):
USF Health is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
USF Health designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE Credit (Nurses):
Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 1.0 contact hours
CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.0 contact hours (0.1 CEUs)
Universal Activity Number: 0376-9999-12-019-H01-P (recorded programs)
Activity Type: application-based
Post-tests, credit request forms, and activity evaluations must be completed online at www.cmeoutfitters.com/TST562 (requires free account activation), and participants can print their certificate or statement of credit immediately (80% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit www.neurosciencecme.com/technical.asp.
Disclosure of Relevant Financial Relationships with Commercial Interests
USF Health and CME Outfitters, LLC, adhere to the ACCME Standards, as well as those of the ACPE, APA, and ANCC, regarding commercial support of continuing medical education. It is the policy of USF Health and CME Outfitters, LLC, that the faculty and planning committee disclose real or apparent conflicts of interest relating to the topics of this educational activity, that relevant conflict(s) of interest are resolved, and also that speakers will disclose any unlabeled/unapproved use of drug(s) or device(s) during their presentation.
A conflict of interest is created when individuals in a position to control the content of CME have a relevant financial relationship with a commercial interest which therefore may bias his/her opinion and teaching. This may include receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, stocks or other financial benefits.
USF Health and CME Outfitters will identify, review, and resolve all conflicts of interest that speakers, authors or planners disclose prior to an educational activity being delivered to learners. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.
Relevant financial relationships exist between the following individuals and commercial interests:
Dr. Thacker has disclosed that she serves as a consultant to Myriad Genetic Laboratories, Inc.; and Boehringer Ingelheim Pharmaceuticals Inc. She serves on the speakers bureaus of Amgen Inc.; Novartis Pharmaceuticals Corporation; Warner Chilcott; Bayer Corporation; sanofi-aventis.
Dr. Pattimakiel has nothing to disclose.
Disclosures were obtained from the planning committee members and are on file in the USF Health Office of Continuing Professional Development (OCPD) for review. Disclosures were obtained from the USF Health OCPD staff: Nothing to Disclose.
Sarah L. Froman, MD (content/peer review) has nothing to disclose.
Ruth Cody, BSN, RN-BC (Content/Peer Reviewer) has no disclosures to report.
Nancy Jennings, MSN, MBA, MHA, RNC (Content/Peer Reviewer) has no disclosures to report.
Monique Johnson, MD, CCMEP (planning committee) has nothing to disclose.
Sharon Tordoff, CCMEP (planning committee) has nothing to disclose.
Joy Bartnett Leffler, MLA, NASW, CSE (planning committee) has nothing to disclose.
Sandra Haas Binford, MAEd (planning committee) has nothing to disclose.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
USF Health, CME Outfitters, LLC, the faculty, and Pfizer Inc. do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.
Equal Opportunity Statement:
Events, activities, programs and facilities of the University of South Florida are available to all without regard to race, color, marital status, gender, sexual orientation, religion, national origin, disability, age, Vietnam or disabled veteran status as provided by law and in accordance with the university's respect for personal dignity.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).
PL-047-092812-02
